Los Angeles Capital Management LLC Coherus Bio Sciences, Inc. Transaction History
Los Angeles Capital Management LLC
- $22.3 Billion
- Q1 2025
A detailed history of Los Angeles Capital Management LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 991,513 shares of CHRS stock, worth $912,191. This represents 0.0% of its overall portfolio holdings.
Number of Shares
991,513
Previous 1,116,142
11.17%
Holding current value
$912,191
Previous $1.54 Million
47.86%
% of portfolio
0.0%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding CHRS
# of Institutions
121Shares Held
64.4MCall Options Held
96.6KPut Options Held
65.3K-
Black Rock Inc. New York, NY11.8MShares$10.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.2MShares$10.3 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY5.26MShares$4.84 Million0.12% of portfolio
-
Tang Capital Management LLC San Diego, CA5.1MShares$4.69 Million0.27% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$2.79 Million0.11% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $71.5M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...